
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12706966
[patent_doc_number] => 20180127488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => Antibodies that Modulate Immunity to Drug Resistant and Latent MTB Infections
[patent_app_type] => utility
[patent_app_number] => 15/850208
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850208 | Antibodies that modulate immunity to drug resistant and latent MTB infections | Dec 20, 2017 | Issued |
Array
(
[id] => 15239649
[patent_doc_number] => 20190374610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => MEDICAL USE OF INTERFERON-LAMBDA FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/469236
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469236
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469236 | MEDICAL USE OF INTERFERON-LAMBDA FOR THE TREATMENT OF FIBROSIS | Dec 19, 2017 | Abandoned |
Array
(
[id] => 17713661
[patent_doc_number] => 11377645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Compositions and methods using Cas9 with enhanced spacer acquisition function
[patent_app_type] => utility
[patent_app_number] => 16/470195
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 9
[patent_no_of_words] => 11381
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470195 | Compositions and methods using Cas9 with enhanced spacer acquisition function | Dec 17, 2017 | Issued |
Array
(
[id] => 12724294
[patent_doc_number] => 20180133265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/842635
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15842635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/842635 | Compositions comprising bacterial strains | Dec 13, 2017 | Issued |
Array
(
[id] => 18412119
[patent_doc_number] => 11666646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Cancer therapy utilizing combination of oral tumor vaccine and immunosuppression inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/472210
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14579
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472210 | Cancer therapy utilizing combination of oral tumor vaccine and immunosuppression inhibitor | Dec 7, 2017 | Issued |
Array
(
[id] => 15432491
[patent_doc_number] => 20200030428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => VIRULENT AEROMONAS VACCINES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/467166
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467166
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467166 | Virulent | Dec 7, 2017 | Issued |
Array
(
[id] => 17569919
[patent_doc_number] => 11318173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Probiotic immunomodulatory compositions
[patent_app_type] => utility
[patent_app_number] => 16/466405
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 23569
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466405 | Probiotic immunomodulatory compositions | Dec 6, 2017 | Issued |
Array
(
[id] => 12766315
[patent_doc_number] => 20180147273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => METHODS FOR DISPLAYING POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/830925
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830925 | METHODS FOR DISPLAYING POLYPEPTIDES AND USES THEREOF | Dec 3, 2017 | Abandoned |
Array
(
[id] => 12259394
[patent_doc_number] => 20180078590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'IN OVO DELIVERY OF PROBIOTIC CULTURES'
[patent_app_type] => utility
[patent_app_number] => 15/823136
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10657
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15823136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/823136 | In ovo delivery of probiotic cultures | Nov 26, 2017 | Issued |
Array
(
[id] => 18349803
[patent_doc_number] => 20230137914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/462630
[patent_app_country] => US
[patent_app_date] => 2017-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462630
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462630 | nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF | Nov 22, 2017 | Pending |
Array
(
[id] => 17748253
[patent_doc_number] => 20220226456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Attenuating bacterial virulence by attenuating bacterial folate transport
[patent_app_type] => utility
[patent_app_number] => 16/348330
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348330 | Attenuating bacterial virulence by attenuating bacterial folate transport | Nov 9, 2017 | Issued |
Array
(
[id] => 14833447
[patent_doc_number] => 20190275124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 16/347510
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347510
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347510 | Antigens for detecting toxoplasma infection by monitoring cellular immunity | Nov 2, 2017 | Issued |
Array
(
[id] => 14196527
[patent_doc_number] => 10265349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Therapeutic microbiota for the treatment and/or prevention of food allergy
[patent_app_type] => utility
[patent_app_number] => 15/801783
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 82
[patent_no_of_words] => 33452
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801783 | Therapeutic microbiota for the treatment and/or prevention of food allergy | Nov 1, 2017 | Issued |
Array
(
[id] => 18647879
[patent_doc_number] => 20230293656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => BACTERIUM CAPABLE OF INDUCING TH1 CELLS
[patent_app_type] => utility
[patent_app_number] => 16/346782
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346782 | Bacterium capable of inducing TH1 cells | Oct 31, 2017 | Issued |
Array
(
[id] => 14230555
[patent_doc_number] => 20190127450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Therapy of multiple organ system failure by anti-toxin antibodies and prophylaxis by anaerobic toxoids
[patent_app_type] => utility
[patent_app_number] => 15/796839
[patent_app_country] => US
[patent_app_date] => 2017-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796839 | Therapy of multiple organ system failure by anti-toxin antibodies and prophylaxis by anaerobic toxoids | Oct 28, 2017 | Abandoned |
Array
(
[id] => 12641193
[patent_doc_number] => 20180105562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => IMMUNE MODULATOR FOR IMMUNOTHERAPY AND VACCINE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 15/795155
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15795155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/795155 | Immune modulator for immunotherapy and vaccine formulation | Oct 25, 2017 | Issued |
Array
(
[id] => 12157370
[patent_doc_number] => 20180028635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'COMPOSITION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/787368
[patent_app_country] => US
[patent_app_date] => 2017-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9632
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15787368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/787368 | COMPOSITION AND USES THEREOF | Oct 17, 2017 | Abandoned |
Array
(
[id] => 17845126
[patent_doc_number] => 11434482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Methods of identifying bacteria comprising binding polypeptides
[patent_app_type] => utility
[patent_app_number] => 15/782616
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 40
[patent_no_of_words] => 47735
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782616 | Methods of identifying bacteria comprising binding polypeptides | Oct 11, 2017 | Issued |
Array
(
[id] => 14868645
[patent_doc_number] => 20190284564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => ENHANCED PROCESSES AND REAGENTS FOR HOST ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 16/337491
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337491 | ENHANCED PROCESSES AND REAGENTS FOR HOST ENGINEERING | Sep 26, 2017 | Abandoned |
Array
(
[id] => 12624537
[patent_doc_number] => 20180100009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN A
[patent_app_type] => utility
[patent_app_number] => 15/717221
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15717221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/717221 | POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN A | Sep 26, 2017 | Abandoned |